H35.3
Conditions
Interventions
Group 1: Questionnaire, Blood sample, OCT-control, Angio-OCT, Autofluoreszenz. Screening visit: Questionnaire, Blood sample, OCT-control, Angio-OCT, Autofluoreszenz, at all the other visits (6, 12, 18
Sponsors
Augenklinik Uniklinik Köln
Eligibility
Sex/Gender
All
Age
50 Years to 100 Years
Inclusion criteria
Inclusion criteria: - First diagnosis of neovascular AMD from 01.01.2016 - written consent of the patient - male and female patients older than 50 years - diagnosis of unilateral CNV in AMD - there is an early form of AMD at the study eye at the time of inclusion
Exclusion criteria
Exclusion criteria: - first diagnosis of unilateral neovascular AMD before 01.01.2016 - bilateral late form of the AMD - eye diseases such as glaucoma, diabetes, high myopia, CNV of other causes and macular edema of other causes - lack of suitability for the study procedures - pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| When does the progression at patients with unilateral AMD of the fellow eye happen? | — |
Secondary
| Measure | Time frame |
|---|---|
| Study participants with disease progression on the fellow eye vs. study participants without progression of the disease on the partner's eye, 6, 12, 18, 24 months after the initial examination. | — |
Countries
Germany
Contacts
Public ContactLebriz Altay
Augenklinik Uniklinik Köln
Outcome results
None listed